Los Angeles Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
41,426
+1,524
| +4% | +$48.2K | ﹤0.01% | 573 |
|
|
2025
Q1 | $1.32M | Buy |
39,902
+14,552
| +57% | +$483K | 0.01% | 488 |
|
|
2024
Q4 | $872K | Hold |
25,350
| – | – | ﹤0.01% | 662 |
|
|
2024
Q3 | $1.01M | Buy |
25,350
+126
| +0.5% | +$5.04K | ﹤0.01% | 650 |
|
|
2024
Q2 | $761K | Hold |
25,224
| – | – | ﹤0.01% | 741 |
|
|
2024
Q1 | $847K | Buy |
25,224
+1,076
| +4% | +$36.1K | ﹤0.01% | 741 |
|
|
2023
Q4 | $780K | Buy |
24,148
+16,555
| +218% | +$535K | ﹤0.01% | 752 |
|
|
2023
Q3 | $249K | Sell |
7,593
-14,093
| -65% | -$462K | ﹤0.01% | 1012 |
|
|
2023
Q2 | $763K | Buy |
+21,686
| New | +$763K | ﹤0.01% | 725 |
|
|
2023
Q1 | – | Sell |
-5,312
| Closed | -$293K | – | 1225 |
|
|
2022
Q4 | $293K | Buy |
+5,312
| New | +$293K | ﹤0.01% | 1043 |
|